North Brunswick, NJ (December 19, 2005). Sophion Bioscience, Inc. (North Brunswick, NJ) and Sophion Bioscience A/S (Ballerup, Denmark) today announced a collaboration with Merck & Co., Inc. to complete the QPatch HT, a 48-channel automated, gigaseal patch clamp system.
QPatch HT is a second-generation instrument based on the QPatch 16, a 16-channel automated patch clamp system marketed by Sophion and in use at pharmaceutical and biotech companies around the world for hERG testing, ion channel screening and drug discovery programs.
About Sophion Bioscience
Sophion Bioscience, Inc. was established in December 2004 as a US subsidiary of Sophion Bioscience A/S (Denmark). The Danish parent company, Sophion Bioscience A/S was founded in July 2000, emerging from a successful research and development program at NeuroSearch. Sophion provides advanced products and integrated solutions for automated patch clamping.
For more information about Sophion Bioscience or the QPatch systems, please contact:
Chris Mathes, Ph.D., VP, General Manager of Sophion Bioscience, Inc. (USA): cma@sophion.com.
page top
Join our mailinglist